1.Efficacy Evaluation of Moxibustion Therapy for Angina Patients with Coronary Artery Disease
Ze ZHANG ; Min CHEN ; Wen-Sheng WU ; Li ZHANG ; Zhen HUA ; Guan-Lin YANG
Journal of Nanjing University of Traditional Chinese Medicine 2015;(2):183-186
OBJECTIVE To evaluate the benefits and side effects of moxibustion therapy for coronary artery disease. METHODS Relevant studies of moxibustion therapy for angina were collected from databases including Pubmed,Embase,Co-chrane library,CNKI,Wanfang Database and CBMDisk.The inclusion and exclusion criteria was applied when the literature was screened,data was extracted and the quality of the included studies were assessed independently.Then,meta-analysis was performed by using RevMan 5 .2 software.RESULTS 1 3 1 8 patients and 1 3 researches about moxibustion therapy for coronary artery disease were collected.The Meta analysis showed that compared with the control group,the western medicine group [RR=1.22,95%CI(1.11,1.33)and the acupuncture group[RR=1.5,95%CI(1.23,1.83),the moxibustion group showed great improvement in relieving angina pectorisis and good effects were shown in the ECG[RR=1.23,95%CI(1.14,1.33).In terms of blood liquids,the moxibustion group showed good effects in regulating triglyceride[SMD=-0.81,95%CI(-1.57,-0.06),low density lipoprotein cholesterin[SMD =-0.55,95%CI(-1.04,-0.06),and high density lipoprotein choles-terol[SMD=0.43,95%CI(0.2,0.65)and the changes were of statistical significance.Compared with the Chinese medicine group,the improvement in angina pectorisis of the moxibustion group showed no statistical significance[RR=1.15,95%CI(0. 9 9 ,1 .3 5).The difference between the changes of total cholesterol in the treatment group and the control group had no statis-tical significance[SMD=-0.74,95%CI(-1.75,0.27).CONCLUSION Moxibustion is a unique TCM therapy in treating angina pectorisis and can be applied in clinical practices.Meanwhile,the outcome of this system was not perfect.And more high quality of randomized controlled trials are needed to verify the effect of the therapy.
2.Effect of Stage-based Acupuncture-moxibustion on Endometrial Thickness After Repeated Implantation Failure in IVF-ET
Jin-Long XU ; Zeng-Rong YANG ; Jing QIAN ; Hai-Na ZHUANG ; Ze-Guan YANG ; Kun HUANG ; Rong ZHAO
Shanghai Journal of Acupuncture and Moxibustion 2018;37(2):200-204
Objective To observe the effect of stage-based acupuncture-moxibustion therapy on the endometrial thickness in patients suffering from repeated implantation failure in IVF-ET (in vitro fertilization and embryo transfer). Method Seventy-two patients suffering from repeated implantation failure in IVF-ET were randomized into two groups. Thirty-six cases in the treatment group were intervened by stage-based acupuncture-moxibustion therapy plus oral administration of Estradiol valerate tablets; the other 36 cases in the control group were prescribed with oral administration of Estradiol valerate tablets alone. The implantation result of IVF-ET was analyzed 3 cycles later. The endometrial thickness was compared before and after the intervention. Result The endometrial thickness of the non-pregnant women increased after the treatment in both groups (P<0.05), and the increase in the treatment group was more significant than that in the control group (P<0.05). The clinical pregnancy rate in the treatment group was significantly higher than that in the control group (P<0.05). Conclusion Stage-based acupuncture-moxibustion therapy can improve the endometrial thickness, promote the growth of endometrium, benefit the implantation of embryo, and enhance the clinical pregnancy rate.
3.Application Analysis of Mobile Equipment and APP in Imaging Diagnostics and Interventional Radiology
Ze-Yang FAN ; Xiao-Qiang TONG ; Hai-Tao GUAN ; Xiu-Ju FAN ; Wen-Feng GAO ; Ying-Hua ZOU
Journal of Medical Informatics 2018;39(1):41-45
By making use of 19 keywords,the paper searches the APP Store for APP related to imaging diagnostics and interventional radiology,analyzes parameters like APP classifications,satisfaction,publisher identity and downloads with statistical methods.The result shows that mobile learning APP,which facilitate imaging diagnostics and interventional radiology doctors with mobile learning,are more popular.
4.Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer.
Yi-Fen ZHANG ; Yang-Bo GUAN ; Bin YANG ; Hong-Yan WU ; Yu-Tian DAI ; Shuang-Jie ZHANG ; Ji-Ping WANG ; Shailendra ANOOPKUMAR-DUKIE ; Andrew K DAVEY ; Ze-Yu SUN
Chinese Medical Journal 2011;124(24):4345-4349
BACKGROUNDHer-2/neu gene overexpression has been found in several malignancies, and is associated with poor prognosis; while its role in the tumorigenesis and progression of prostate cancer (PCa) is still controversial. This study aimed to evaluate the prognostic value of Her-2/neu protein expression and clinicopathologic factors in antiandrogen-treated Chinese men with PCa for disease progression and PCa-specific death.
METHODSHer-2/neu protein expression was determined using immunohistochemistry (IHC) in specimens collected from 124 prostate biopsies and transurethral resection of prostate (TURP) from seven prostate cancer patients.
RESULTSHer-2/neu protein expression was 0, 1+, 2+, and 3+ in 40 (30.5%), 8 (6.1%), 67 (51.1%), and 16 (12.2%) cases, respectively. Her-2/neu protein expression showed significant correlation as judged by Gleason score (P = 0.049), clinical tumor-node-metastases (cTNM) stage (P = 0.018) and disease progression (P = 0.001), but did not correlate with prostate-specific antigen (PSA) (P = 0.126) or PCa-specific death (P = 0.585). PSA (P = 0.001), Gleason score (P = 0.017), cTNM (P = 0.000) and Her-2/neu protein expression (P = 0.001) had prognostic value for evaluating the progression of PCa in univariate analysis. In Kaplan-Meier plots, both Gleason score (P = 0.035) and cTNM (P = 0.013) correlated with PCa-specific death. In multivariate analysis, only cTNM was significant for both disease progression (P = 0.001) and PCa-specific death (P = 0.031).
CONCLUSIONSHer-2/neu protein expression is significantly correlated with Gleason score, cTNM and disease progression, although it is not an independent predictor of disease progression and PCa-specific death. cTNM staging serves as an independent prognostic factor for disease progression and PCa-specific death.
Aged ; Aged, 80 and over ; Disease Progression ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prognosis ; Prostatic Neoplasms ; metabolism ; mortality ; pathology ; Receptor, ErbB-2 ; metabolism
5.Synthesis of phenylacetamide derivatives and their protective effects on islet cell damage induced by palmitic acid
Ai-Yun LI ; Li GUAN ; Wan-Zhen SU ; Yang-Yang LU ; Sheng-Jie ZHANG ; Wei-Ze LI ; Xiang-Ying JIAO
Chinese Pharmacological Bulletin 2024;40(6):1130-1136
Aim To design and synthesize a series of phenylacetamide derivatives with different substituted phenylacetic acid as raw materials,and to investigate the protective effects of the compound on the damage of pancreatic β cells induced by palmitate acid(PA).Methods Min6 cells were cultured and divided into B blank control group,PA treatment group and PA+compounds group.The viability of Min6 cells was de-tected by CCK-8.The protein expressions of TXNIP and NLRP3 were observed by Western blot.MDA con-tent and SOD activity were detected by MDA and SOD kit.The insulin secretion of Min6 islet cells was meas-ured with insulin ELISA kit.Results A total of 10 phenylacetamide derivatives were designed and synthe-sized.Their structures were confirmed by 1H NMR and ESI-MS.Pharmacological activity study showed that most of the compounds had protective effects on islet βcells,among which LY-6 and LY-8 had stronger pro-tective effects than PA model group,with the cell via-bility of 61.4%,and LY-6 had the highest cell activi-ty,reaching to 104.9%.Compared with PA group,the protein expression of TXNIP and NLRP3 decreased in LY-6 and LY-8 groups,MDA content decreased and SOD activity increased,and insulin secretion of Min6 cell increased.Conclusions LY-6 and LY-8 inhibit TXNIP expression and decrease the activation of NL-RP3 inflammasome,and decrease the production of MDA and increase SOD activity,and thus reducing is-let β cells apoptosis and increasing insulin secretion.Therefore,the compound LY-6 could serve as a poten-tial anti-diabetic new chemical entity.
6.Phylogenetic Analysis of Ruminant Theileria spp. from China Based on 28S Ribosomal RNA Gene.
Huitian GOU ; Guiquan GUAN ; Miling MA ; Aihong LIU ; Zhijie LIU ; Zongke XU ; Qiaoyun REN ; Youquan LI ; Jifei YANG ; Ze CHEN ; Hong YIN ; Jianxun LUO
The Korean Journal of Parasitology 2013;51(5):511-517
Species identification using DNA sequences is the basis for DNA taxonomy. In this study, we sequenced the ribosomal large-subunit RNA gene sequences (3,037-3,061 bp) in length of 13 Chinese Theileria stocks that were infective to cattle and sheep. The complete 28S rRNA gene is relatively difficult to amplify and its conserved region is not important for phylogenetic study. Therefore, we selected the D2-D3 region from the complete 28S rRNA sequences for phylogenetic analysis. Our analyses of 28S rRNA gene sequences showed that the 28S rRNA was useful as a phylogenetic marker for analyzing the relationships among Theileria spp. in ruminants. In addition, the D2-D3 region was a short segment that could be used instead of the whole 28S rRNA sequence during the phylogenetic analysis of Theileria, and it may be an ideal DNA barcode.
Animals
;
Base Sequence
;
China
;
DNA, Ribosomal/chemistry/genetics
;
Molecular Sequence Data
;
Phylogeny
;
RNA, Ribosomal, 28S/genetics
;
Ruminants
;
Sequence Alignment
;
Sequence Analysis, DNA/veterinary
;
Theileria/*classification/genetics/isolation & purification
;
Theileriasis/*parasitology
7.Direct reprogramming of porcine fibroblasts to neural progenitor cells.
Xiu-Ling XU ; Ji-Ping YANG ; Li-Na FU ; Ruo-Tong REN ; Fei YI ; Keiichiro SUZUKI ; Kai LIU ; Zhi-Chao DING ; Jing QU ; Wei-Qi ZHANG ; Ying LI ; Ting-Ting YUAN ; Guo-Hong YUAN ; Li-Na SUI ; Di GUAN ; Shun-Lei DUAN ; Hui-Ze PAN ; Ping WANG ; Xi-Ping ZHU ; Nuria MONTSERRAT ; Ming LI ; Rui-Jun BAI ; Lin LIU ; Juan Carlos IZPISUA BELMONTE ; Guang-Hui LIU
Protein & Cell 2014;5(1):4-7
Animals
;
Cellular Reprogramming
;
Dentate Gyrus
;
cytology
;
Fibroblasts
;
cytology
;
Mice
;
Neural Stem Cells
;
cytology
;
transplantation
;
Swine
8.Different distributions of nerve demyelination in chronic acquired multifocal polyneuropathies.
Xia-Jun ZHOU ; Ying ZHU ; De-Sheng ZHU ; Lu HAN ; Qian-Yun LIU ; Xiao-Niu LIANG ; Yong HAO ; Ze-Zhi LI ; Yang-Tai GUAN
Chinese Medical Journal 2020;133(21):2558-2564
BACKGROUND:
Multifocal motor neuropathy (MMN), Lewis-Sumner syndrome (LSS), and many chronic inflammatory demyelinating polyradiculoneuropathies (CIDPs) are representative of acquired multifocal polyneuropathy and are characterized by conduction block (CB). This retrospective study aimed to investigate the demyelinating distribution and the selective vulnerability of MMN, LSS, and CIDP with CB (CIDP-CB) in nerves.
METHODS:
Fifteen LSS subjects (107 nerves), 24 MMN subjects (176 nerves), and 17 CIDP-CB subjects (110 nerves) were included. Their clinical information was recorded, blood and cerebrospinal fluid tests were conducted, and nerve conductions of the median, ulnar, radial, peroneal, and tibial nerves were evaluated. CB, temporal dispersion, distal motor latency (DML), and F-wave latency were recorded, and nerve conduction velocity, terminal latency index, and modified F-wave ratio were calculated.
RESULTS:
CB was more likely to occur around the elbow in CIDP-CB than in MMN (78.6% vs. 6.8%, P < 0.01) but less likely to occur between the wrist and the elbow than in LSS (10.7% vs. 39.3%, P < 0.05). Tibial nerve CB was most frequently observed in MMN (47.4%, P < 0.05). CIDP-CB was characterized by a prolonged DML in all nerves, and slow motor nerve velocity of the upper limb was significant when CB nerves were excluded (P < 0.05).
CONCLUSIONS
We report the different distributions of segmental and diffuse demyelination of the ulnar and tibial nerves in LSS, MMN, and CIDP-CB. These distinct distributions could help in differentiating among these conditions.
Humans
;
Neural Conduction
;
Peripheral Nerves
;
Polyneuropathies
;
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
;
Retrospective Studies
9.Active Ingredients of Reduning Injection Maintain High Potency against SARS-CoV-2 Variants.
Zhen XIAO ; Huan XU ; Ze-Yang QU ; Xin-Yuan MA ; Bo-Xuan HUANG ; Meng-Si SUN ; Bu-Qing WANG ; Guan-Yu WANG
Chinese journal of integrative medicine 2023;29(3):205-212
OBJECTIVE:
To investigate the anti-coronavirus potential and the corresponding mechanisms of the two ingredients of Reduning Injection: quercetin and luteolin.
METHODS:
A pseudovirus system was designed to test the efficacy of quercetin and luteolin to inhibit SARS-CoV-2 infection and the corresponding cellular toxicity. Luteolin was tested for its activities against the pseudoviruses of SARS-CoV-2 and its variants. Virtual screening was performed to predict the binding sites by Autodock Vina 1.1.230 and PyMol. To validate docking results, surface plasmon resonance (SPR) was used to measure the binding affinity of the compounds with various proteins of the coronaviruses. Quercetin and luteolin were further tested for their inhibitory effects on other coronaviruses by indirect immunofluorescence assay on rhabdomyosarcoma cells infected with HCoV-OC43.
RESULTS:
The inhibition of SARS-CoV-2 pseudovirus by luteolin and quercetin were strongly dose-dependent, with concentration for 50% of maximal effect (EC50) of 8.817 and 52.98 µmol/L, respectively. Their cytotoxicity to BHK21-hACE2 were 177.6 and 405.1 µmol/L, respectively. In addition, luetolin significantly blocked the entry of 4 pseudoviruses of SARS-CoV-2 variants, with EC50 lower than 7 µmol/L. Virtual screening and SPR confirmed that luteolin binds to the S-proteins and quercetin binds to the active center of the 3CLpro, PLpro, and helicase proteins. Quercetin and luteolin showed over 99% inhibition against HCoV-OC43.
CONCLUSIONS
The mechanisms were revealed of quercetin and luteolin inhibiting the infection of SARS-CoV-2 and its variants. Reduning Injection is a promising drug for COVID-19.
Humans
;
SARS-CoV-2
;
COVID-19
;
Luteolin
;
Quercetin
10.Active Ingredients of Reduning Injections Maintain High Potency against SARS-CoV-2 Variants.
Zhen XIAO ; Huan XU ; Ze-Yang QU ; Xin-Yuan MA ; Bo-Xuan HUANG ; Meng-Si SUN ; Bu-Qing WANG ; Guan-Yu WANG
Chinese journal of integrative medicine 2022;():1-8
OBJECTIVE:
To investigate the anti-coronavirus potential and the corresponding mechanisms of the two ingredients of Reduning Injection: quercetin and luteolin.
METHODS:
A pseudovirus system was designed to test the efficacy of quercetin and luteolin to inhibit SARS-CoV-2 infection and the corresponding cellular toxicity. Luteolin was tested for its activities against the pseudoviruses of SARS-CoV-2 and its variants. Virtual screening was performed to predict the binding sites by Autodock Vina 1.1.230 and PyMol. To validate docking results, surface plasmon resonance (SPR) was used to measure the binding affinity of the compounds with various proteins of the coronaviruses. Quercetin and luteolin were further tested for their inhibitory effects on other coronaviruses by indirect immunofluorescence assay on rhabdomyosarcoma cells infected with HCoV-OC43.
RESULTS:
The inhibition of SARS-CoV-2 pseudovirus by luteolin and quercetin were strongly dose-dependent, with concentration for 50% of maximal effect (EC50) of 8.817 and 52.98 µmol/L, respectively. Their cytotoxicity to BHK21-hACE2 were 177.6 and 405.1 µmol/L, respectively. In addition, luetolin significantly blocked the entry of 4 pseudoviruses of SARS-CoV-2 variants, with EC50 lower than 7 µmol/L. Virtual screening and SPR confirmed that luteolin binds to the S-proteins and quercetin binds to the active center of the 3CLpro, PLpro, and helicase proteins. Quercetin and luteolin showed over 99% inhibition against HCoV-OC43.
CONCLUSIONS
The mechanisms were revealed of quercetin and luteolin inhibiting the infection of SARS-CoV-2 and its variants. Reduning Injection is a promising drug for COVID-19.